SCHEMBL7232668

SCHEMBL7232668

COC(=O)[C@H]1C[C@@H](C(=O)OC)[C@H](CO)[C@@H]1CNC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.39
▸ EPHX1 P07099 1/20 0.36
▸ KMT2A Q03164 4/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ NR1H2 P55055 1/20 0.33
▸ ACACB O00763 2/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ CACNA1H O95180 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ ACACA Q13085 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232674 0.95 BTK (0.37) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7230501 0.89 EPHX1 (0.36) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7230862 0.84 BTK (0.37) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7232715 0.84 KMT2A (0.34) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7230514 0.84 BTK (0.37) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7235642 0.80 BTK (0.38) TDP1EPHX1KMT2AGAANR1H2
SCHEMBL7232725 0.80 BTK (0.34) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL7234329 0.79 CHRM2 (0.39) KMT2AMEN1ALDH1A1TSHRMAPK1
SCHEMBL20066214 0.79 EPHX1 (0.39) TDP1EPHX1KMT2AMEN1ALDH1A1
SCHEMBL228311 0.78 EPHX1 (0.41) TDP1EPHX1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518305-B1 For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase ABBOTT LABORATORIES 2003-02-11 — — US disclosed
Send feedback